Malignes Wachstum

M.J Duffy, A van Dalen, C Haglund, L Hansson, R Klapdor, R Lamerz, O Nilsson, C Sturgeon, O Topolcan, Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines. European Journal of Cancer. ,vol. 39, pp. 718- 727 ,(2003) , 10.1016/S0959-8049(02)00811-0

S Falkenreck, F Safi, H G Beger, W Schlosser, Prognostic value of CA 19-9 serum course in pancreatic cancer. Hepato-gastroenterology. ,vol. 45, pp. 253- 259 ,(1998)

S. Aloe, R. DAlessandro, A. Spila, P. Ferroni, S. Basili, R. Palmirotta, M. Carlini, F. Graziano, R. Mancini, S. Mariotti, M. Cosimelli, M. Roselli, F. Guadagni, Prognostic value of serum and tumor tissue CA 72-4 content in gastric cancer International Journal of Biological Markers. ,vol. 18, pp. 21- 27 ,(2003) , 10.5301/JBM.2008.1151

Hiromitsu Saisho, Seiki Matsuno, Osamu Ishikawa, Hiroshi Ishii, Jyunji Furuse, Hideyuki Wakasugi, Tosiya Sato, Shinji Yokoyama, Shuichi Okada, CA 19-9 in evaluating the response to chemotherapy in advanced pancreatic cancer Hepato-gastroenterology. ,vol. 44, pp. 279- 283 ,(1997)

S. Eichinger, K. Lechner, Hämorrhagische und thromboembolische Komplikationen bei malignen Erkrankungen Springer, Berlin, Heidelberg. pp. 799- 809 ,(2004) , 10.1007/978-3-662-06670-6_34

Mark Jeffery, Brigid E Hickey, Phil N Hider, Adrienne M See, Follow-up strategies for patients treated for non-metastatic colorectal cancer Cochrane Database of Systematic Reviews. ,vol. 2016, pp. 1- 27 ,(2016) , 10.1002/14651858.CD002200.PUB3

Michael C. Perry, Hepatotoxicity of chemotherapeutic agents Seminars in Oncology. ,vol. 9, pp. 65- 74 ,(1982) , 10.5555/URI:PII:0093775482900082

Ian Jacobs, Robert C. Bast, The CA 125 tumour-associated antigen: a review of the literature Human Reproduction. ,vol. 4, pp. 1- 12 ,(1989) , 10.1093/OXFORDJOURNALS.HUMREP.A136832

J M Duk, K H Groenier, H W de Bruijn, H Hollema, K A ten Hoor, A G van der Zee, J G Aalders, Pretreatment serum squamous cell carcinoma antigen: a newly identified prognostic factor in early-stage cervical carcinoma Journal of Clinical Oncology. ,vol. 14, pp. 111- 118 ,(1996) , 10.1200/JCO.1996.14.1.111

G Scambia, P Benedetti Panici, E Foti, M Amoroso, G Salerno, G Ferrandina, F Battaglia, S Greggi, A De Gaetano, G Puglia, Squamous cell carcinoma antigen: prognostic significance and role in the monitoring of neoadjuvant chemotherapy response in cervical cancer. Journal of Clinical Oncology. ,vol. 12, pp. 2309- 2316 ,(1994) , 10.1200/JCO.1994.12.11.2309